Introduction
The hemato-lymphoid system is a paradigmatic, somatic stem cell maintained organ with enormous cellular turnover, i.e. the continuous de novo generation and subsequent death of cells. It is estimated that in a 70 kg adult human individual about 3x10 5 erythrocytes and 3x10 4 white blood cells are produced per second in steady-state (steady-state hematopoiesis)
and it is documented that during specific demand, e.g. upon blood loss or infectious challenges, cellular production can increase several-fold over baseline levels (demandadapted hematopoiesis). Obviously, such high cellular throughput requires tight control, as hematopoietic failure (e.g. aplasia) or excess (e.g. leukemia) within short time is not compatible with life. Equally obvious, the control mechanism needs to involve "longdistance" regulatory feedback loops as the blood cell production sites in bone marrow (BM) are spatially disconnected from blood cell effector sites in the periphery.
Blood cell production is hierarchically organized with hematopoietic stem cells (HSCs) at the top which ensure via both self-renewal and differentiation to multipotent and stepwise blood lineage-committed progenitors the continuous production of all different blood cells throughout the life time of an individual 1 . This series of differentiation steps allows both homeostatic maintenance of blood cell levels under basal conditions as wells as a high degree of flexible adaptation to increase blood cell output, in response to disturbances of the hematopoietic equilibrium and to specific demand, respectively.
The hematopoietic response to acute systemic bacterial infection, often referred to as emergency myelopoiesis, is a prime example for demand-adapted hematopoiesis. In contrast to less severe local infection not causing systemic symptoms and blood count alterations, lymphopenia and neutropenia to lymphocytosis and neutrophilia. Despite differences in kinetics and magnitude of the responses elicited by distinct pathogens the crucial initial step is shared in any of these settings and involves sensing and recognition of a given pathogen.
Specific antigen receptor-independent pathogen recognition in the innate branch of the immune system is accomplished through specialized pattern-recognition receptors (PRRs) which sense pathogen-associated molecular patterns (PAMPs). Toll-like receptors (TLRs) belong to the PRR family and recognize conserved microbial products derived from exogenous pathogens and possibly also some host derived endogenous ligands [2] [3] [4] [5] . Ligation of TLRs, via sophisticated downstream signaling cascades, induces cell-and context-dependent proliferation, differentiation and migration, as well as protein production and secretion, all processes geared to activate and orchestrate efficient immune response against insulting invaders 6 .
The classical concept of induction of emergency myelopoiesis assumes that activation of PRRs on tissue-resident hematopoietic and non-hematopoietic cells at the site of pathogen entry triggers a cascade of signaling events, leading to release of immune cell attractants (e.g. chemokines) and survival and maturation factors (e.g. cytokines). Chemokines recruit immune cells such as granulocytes from the blood into the affected tissue where they exert their effector function [7] [8] . In parallel, cytokines with pleiotropic functions stimulate immune cells locally, and, upon insufficient local control of the infection, increase to reach relevant systemic levels, ultimately enhancing production of myelo-monocytic cells from myeloidcommitted precursors in the BM in order to replenish consumed peripheral cells [9] [10] . Thus, as the kidney senses low oxygen pressure and subsequently increases erythropoietin (EPO) secretion in order to stimulate red blood cell production upon demand 11 , environmental contact organs, e.g. the lung with high numbers of local phagocytic cells might be particularly efficient in producing myeloid cell stimulating and differentiating factors that would ensure appropriate increase of innate immune cell production in BM upon need 9 .
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From Takizawa et al. 5 However, recent findings suggest that the hematopoietic response to infection and inflammation has been shaped by evolution in a more sophisticated way involving complementary direct and indirect pathways at inflammatory and hematopoietic sites: cytokines, beyond providing mere stimuli for proliferation, instruct linage choices; hematopoietic and non-hematopoietic cells at primary site of blood production, i.e. in BM, are able to sense pathogens and react with appropriate protective responses; and finally, HSCs themselves, that were previously thought to be largely protected from toxic or infectious challenges in their niches [12] [13] , play a more immediate and active role in the emergency response. In this review, we will try to integrate these novel insights and highlight the shortterm protective advantages but also point to potential long-term effects that might support development of hematopoietic disease, especially in an aging population.
Expression of inflammation and infection responsive receptors on hematopoietic cells in bone marrow
In locally non-controlled infection, a large number of soluble factors are rapidly increased in serum and are able to act at hematopoietic sites in BM. These factors include a) conserved infectious agent products or "patterns" (e.g. bacterial or fungal specific membrane products, or species-specific DNA and RNA motifs), b) cytokines (e.g. colony-stimulating factors, interleukins, interferons), and c) mobility factors (e.g. chemokines). In order to react to either of them, responsive cells need to express the respective receptors.
Hemato-lymphoid differentiation and maturation from HSCs to terminally 
Expression of inflammation and infection responsive receptors on non-hematopoietic cells in bone marrow
The concept that the highly specialized BM microenvironment participates in HSC maintenance as well as guidance of hematopoietic differentiation has been proposed for the last decades 39 and corroborated by experimental observation that long-term survival of HSPCs can be achieved by in vitro co-culture on stromal feeder layers [40] [41] [42] . The first definitive in vivo proof for the existence of a HSC "niche" came from two studies using genetic and pharmacological approaches to specifically manipulate osteoblasts function [43] [44] ; B) induction of a molecular program in progenitor cells that induces differentiate to a specific lineage (instructive model) ( Figure   3 ). In recent studies it was demonstrated that enforced expression of cytokine receptors or respective transcription factors in either alternatively committed or non-committed progenitors leads to conversion or instruction to one lineage at cost of others, respectively [61] [62] [63] [64] . Also, it was demonstrated by long-term tracking of single cell differentiation processes that indeed GMPs can be instructed by G-CSF or M-CSF to differentiate into granulocytes or macrophages, respectively 65 . It seems thus reasonable to assume that also in vivo, particularly during infection when myeloid-acting cytokines are highly elevated, early non-committed progenitors are selectively instructed to differentiate into cells of demand, i.e. myelomonocytic lineages, resulting in emergency myelopoiesis ( Figure 3B ). Although less well studied for lymphocyte responses that do not necessarily rely on de novo production from HSPCs, it is interesting to note that lymphopenia causes an elevation of IL-7, possibly also supporting early lymphopoiesis in BM 66 .
A complementary mechanism to assure enhanced hematopoietic production would be Table 1 ).
Therefore, despite their high potential for cell production, HSCs were believed to be unresponsive to lineage differentiation-promoting cytokines during infection and inflammation. This could make sense as initiation of differentiation without retention of selfrenewal capacity, would result in life-threatening HSC loss. Indeed, most HSC are in relative quiescence in steady-state, i.e. divide infrequently compared to hematopoietic progenitor cells that lack self-renewal capacity but harbor high proliferation capacity [73] [74] [75] [76] [77] . However, lack of response of HSCs to infection and inflammation would also imply that enhanced hematopoiesis during these processes would rely solely on the progenitor compartment, possibly not containing sufficient capacity to support a long-term sustained response. To cope with this demand, an increased self-renewal and progenitor generation response by HSCs might be beneficial for the organism. Figure 6 ).
Evolutionary benefits of inflammatory activation of early hematopoiesis
Given the above discussed, it is obvious that evolution shaped the hematopoietic response during infection and inflammation in a way that early hematopoiesis is involved in fast, versatile, efficient and sustained defense responses at several layers.
In a first wave of response upon local bacterial or fungal infection, mature blood, 
contribution of TLR-and non-TLR-mediated pathways need to be addressed in ongoing and future studies.
Potential risks of inflammatory activation of early hematopoiesis
While acute and rapid demand-adapted recruitment of HSCs from quiescence to active cycling and subsequent blood production is likely an economically efficient way to avoid excess generation and storage of otherwise not used differentiation-ready progenitor cells, chronic inflammation or infection might be associated with activation of HSCs that could lead to detrimental effects. , the system would ensure at any given time in steady-state, that a quiescent HSC fraction is largely protected from genome-toxic events by lack of DNA replication and through highly-effective nonhomologous end joining, which, however, due to errors might in some cases still allow genetic altered clones to arise [103] [104] [105] [106] . We speculate that chronic infection and inflammation, inducing high proliferation of most HSCs might lead to both exhaustion of the HSC pool and an even higher risk to accumulate genetic alterations in HSCs. These genetically altered HSCs, which are supposedly not competitive and die in steady-state environments, might be rescued by stimulants of the inflammatory environment, or "cancer cell niche" [107] [108] , and finally could . This does not come as a surprise given the long-known association of inflammatory signaling and cancer [112] [113] [114] [115] . In accordance, recent findings revealed that alterations leading to constitutive active TLR signaling pathways, thus mimicking chronic infection and inflammation, can provide the basis for malignant transformation of HSC 116 and that TLR4 and downstream signaling molecules are found to be constitutively up-regulated in
HSPCs from MDS patients [117] [118] .
Future directions and clinical implications
It has become clear during the last decades that the early hematopoietic system in BM We are convinced that further research on the versatile demand-adapted response of the hematopoietic system will not only provide new basic insights and therapeutic options for hematologists, oncologists, immunologists and infectious disease specialists, but will likely also instruct on principle mechanisms of homeostasis and regeneration upon infection and inflammation in other stem-cell maintained organ systems as skin, gut and brain. 
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The balance between these three cell fates is tightly regulated in order to ensure balanced blood cell production over the lifetime of an individual. With increased proliferative history in the HSC compartment, the probability of acquiring genetic alterations ("hits") in HSCs increases, but efficient counteractive mechanisms (e.g. apoptosis, DNA repair) have evolved to remove or correct genetically altered HSCs from the pool (upper panel). It can be hypothesized that under chronic or repetitive inflammation the likelihood of genetic hit acquisition and subsequent accumulation in HSC is increased by two major mechanisms: First,
